Abcellera Biologics is trading 4.88% higher at $12.67 in pre-market on October 28, as biotech shares rally on positive clinical-trial and regulatory developments elsewhere.
- The company’s release page lists no October 27–28 announcement; its next scheduled quarterly results are November 9.
- The move follows a 6.21% gain on October 27 and a close at $12.83.
- Broader risk-on sentiment is also supportive.